News

For several weeks, it looked like the former South Dakota State star was going to have to find a new NFL home. Even while ...
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
The University of Maryland School of Medicine (UMSOM) is pleased to formally acknowledge the 11 newest members of its Board of Visitors, who have joined the board over the past two academic years.
A 333-unit community, Hillcrest Apartments, will be developed directly across from Amgen’s headquarters in Thousand Oaks, ...
Invesco LLC slashed its Amgen holdings by 20.2%, unloading 2,310 shares worth roughly $2.85 million. This sale brought ...
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
Talented female scientists are being pushed out of cancer research due to gender discrimination, ageism and an absence of mentorship, funding and job secur ...